Event date
  • CME Activities
  • COVID-19
  • Mental Health
  • Prevention
  • Psychiatry
  • Wellness
The 2020 – 2021 COVID pandemic has led to multiple unexpected outcomes for providers and medical staff on the frontlines of treatment.  In addition to risk and worry over infectious exposure, staff and providers have also had to deal with high census, increased critical care bed usage, the steep learning curve of treatment for a novel illness, as well as novel stressors in their personal lives during this time.  Studies report epidemic proportions of provider and staff burnout, leading to negative mental health outcomes, turnover, poor morale, and in some instances, a desire for staff and p
  • CME Activities
  • Critical Care
  • Emergency
  • Neurology
  • Tenecteplase
  • Thrombolytics
Intravenous thrombolytics is the mainstay of acute therapy in ischemic stroke.  While alteplase has been FDA-approved for this indication since the 1990s, Tenecteplase has recently gained traction for usage in acute ischemic stroke treatment as well.  This lecture summarizes the existing evidence and practical considerations for use of Tenecteplase in stroke therapy.